MAPT and Alzheimer disease: We detected no total tau protein elevation in the majority of ABS + COG patients, indicating no further neurodegenerative process like that observed in rapidly progressing Alzheimer’s disease in apoliprotein E (APOE) ε4-carriers (Wattmo et al. 2020).